EP 1380

1380. The Secret to Staying DANGEROUS After 50

In this episode of The Human Upgrade, Host Dave Asprey sits down with Josh Felber and Jay Campbell, cofounders of BioLongevity Labs, for a deep dive into peptides, mitochondrial function, and the emerging compounds shaping the next era of biohacking and longevity. They break peptides down in simple terms as amino acid signaling molecules, then explore real-world application including peptide pens versus vials, pharmacokinetics and PK curves, growth hormone–supporting peptides like Tesamorelin, Ipamorelin, and CJC, and why convenience drives compliance. The conversation covers mitochondrial-focused compounds such as SS31 now known as elamipretide and MOTS-c, a long-acting folistatin-based peptide aimed at myostatin regulation and muscle retention, and Klotho as a longevity-associated protein tied to endothelial function, kidney health, and cognitive performance, while emphasizing intelligent experimentation, dose awareness, and smarter-not-harder strategies for improving human performance. 

Subscribe To The Human Upgrade

In this Episode of The Human Upgrade™...

Peptides can change how you heal, lean out, build muscle, and age, but only if you stop taking influencer advice and start thinking like a scientist. 

 

-Get a discount from BIOLONGEVITY LABS by using code ‘Dave’ at: https://biolongevitylabs.com/ 

 

Host Dave Asprey sits down with Josh Felber and Jay Campbell for a deep, practical conversation on what peptides actually are, how they work in the body, and how to use them without doing something dumb. Josh Felber and Jay Campbell are both cofounders of BioLongevity Labs and longtime leaders in the peptide and performance space. Josh is also the host of the Making Bank podcast and a serial entrepreneur in health. Jay has spent more than a decade researching and teaching advanced peptide protocols and performance strategies. 

 

They break peptides down in plain English as chains of amino acids that act like signaling molecules, then get into what matters in the real world: delivery methods, dosing, and why pharmacokinetics and timing decide whether something works. You’ll hear why peptide pens feel like a huge upgrade over vials and syringes, why Dave wants patches and microneedle tech next, and how convenience can make the difference between consistency and quitting. 

 

Dave and the guys also go deep on mitochondria and longevity. They talk about SS31, now called elamipretide, and why it focuses on mitochondrial membranes and cardiolipin. They cover MOTS-c as a “turbocharger” peptide that people often feel fast, especially if they feel metabolically sluggish. They get into growth hormone peptides like Tesamorelin, Ipamorelin, and CJC, plus why MK-677 sounds convenient but can come with tradeoffs like appetite and other downstream effects. 

 

Then the conversation turns into what’s new. Jay shares what he claims is a new long-acting folistatin-style compound called FLGR 242, designed to stay active for weeks. He frames it as a potential solution for GLP users who worry about losing muscle. They also talk about Klotho, what it does in aging, why it is hard to stabilize, and why Jay believes small dosing matters because of kidney risk at higher levels. Dave ties Klotho back to endothelial function and kidney protection, and they swap stories about what people report noticing. 

 

You’ll Learn: 

  • What peptides are, explained without jargon
  • Why delivery matters and why pens beat mixing vials all day
  • How PK curves change real results and dosing schedules
  • What elamipretide means for mitochondria and longevity
  • Why MOTS-c can feel like a fast energy shift for some people
  • How Tesamorelin, Ipamorelin, and CJC fit into growth hormone support
  • Why MK-677 sounds easy but can bring unwanted effects
  • What Jay claims FLGR 242 does for myostatin, muscle, and fat loss
  • Why Clotho shows up in longevity research and why dose matters

 

Keywords: peptides, biohacking, Dave Asprey, Jay Campbell, Josh Felber, BioLongevity Labs, mitochondrial peptides, elamipretide SS31, MOTS-c, growth hormone peptides, Tesamorelin, Ipamorelin, CJC-1295, MK-677, folistatin, myostatin inhibitor, FLGR 242, Clotho peptide, longevity science, anti-aging, human performance, muscle growth, fat loss, GLP-1 muscle preservation, pharmacokinetics, peptide dosing, nootropics, functional medicine, metabolism, endothelial function, kidney protection 

 

Resources:   

 

“I think this is one of the greatest performance enhancement products in the history of science.”

Jay Campbell

0:00 – Trailer 

A rapid-fire preview of the biggest claims in the episode, including next-generation muscle peptides, mitochondrial upgrades, and longevity compounds. 

1:22 – Introduction to Peptides 

Peptides explained in plain English as amino acid signaling molecules and why they have become central to modern biohacking. 

7:52 – Peptide Delivery Systems & Pens 

Why peptide pens are replacing traditional reconstitution and syringes, how dosing becomes easier, and why convenience improves consistency. 

14:22 – Safety & Regulation of Peptides 

Risk profiles, overdosing mistakes, research chemical status, and how regulation affects access and physician guidance. 

19:22 – SS-31 & Mitochondrial Health 

Elamipretide formerly SS-31, cardiolipin repair, mitochondrial membranes, and why mitochondrial function drives energy and longevity. 

26:22 – Blending Peptides & Cross-Linking 

Whether mixing peptides reduces efficacy, what cross-linking actually means, and how storage impacts stability over time. 

38:22 – Growth Hormone Peptides 

Tesamorelin, Ipamorelin, CJC, MK-677, and how to stimulate growth hormone intelligently without long-term suppression. 

44:22 – FLGR-242: The New Myostatin Inhibitor 

A long-acting folistatin-based peptide, myostatin regulation, muscle retention during GLP use, and bold performance claims. 

54:22 – Melanin & Consciousness 

Melanin as more than pigment, its potential role in brain energy and light biology, and the capacitor analogy for cellular charge. 

57:22 – Clotho: The Longevity Peptide 

Clotho as an age-declining protein linked to endothelial function, kidney protection, cognitive performance, and cautious dosing. 

59:25 – Regulatory Landscape & Future of Peptides 

The evolving FDA environment, compounding battles, and why this may be a golden window for peptide experimentation. 

 

Thank you to our sponsors!   

Enjoy the show!

LISTEN:

“Follow” or “subscribe” to The Human Upgrade™ with Dave Asprey on your favorite podcast platform.

REVIEW: 

Go to Apple Podcasts at daveasprey.com/apple and leave a (hopefully) 5-star rating and a creative review.

FEEDBACK:

Got a comment, idea or question for the podcast? Submit via this form!

SOCIAL:

Follow @thehumanupgradepodcast on Instagram and Facebook.

JOIN: 

Learn directly from Dave Asprey alongside others in a membership group: ourupgradecollective.com.

Subscribe To The Human Upgrade

Similar Episodes

podcast-divider-bottom.png

Subscribe To The Human Upgrade

BOOKS

4X NEW YORK TIMES
BEST-SELLING SCIENCE AUTHOR

AVAILABLE NOW

Smarter
Not Harder

Smarter Not Harder: The Biohacker’s Guide to Getting the Body and Mind You Want is about helping you to become the best version of yourself by embracing laziness while increasing your energy and optimizing your biology.

If you want to lose weight, increase your energy, or sharpen your mind, there are shelves of books offering myriad styles of advice. If you want to build up your strength and cardio fitness, there are plenty of gyms and trainers ready to offer you their guidance. What all of these resources have in common is they offer you a bad deal: a lot of effort for a little payoff. Dave Asprey has found a better way.
media-section-06-img.png

Also Available

footer-line-img.png

Start hacking your way to better than standard performance and results.

Receive weekly biohacking tips and tech by becoming a Dave Asprey insider.

By sharing your email, you agree to our Terms of Service and Privacy Policy